Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide ...

Antibiotic optimisation through therapeutic drug monitoring (TDM) is a key strategy in tackling antimicrobial resistance. However, current quantification methods rely on laboratory-based equipment, ...

Purpose. The feasibility of using a limitedsampling algorithm for administration of vancomycin for treatment of vascular-access-related bacteremia in outpatient high flux hemodialysis was investigated ...

Vancomycin has only rarely been implicated as a cause of thrombocytopenia, and there is only limited evidence that this complication is caused by immune mechanisms. We conducted a study to determine ...

Vancomycin is a common antibiotic used to treat gram-positive bacterial infections. It targets a key building block of the bacterial cell wall called Lipid II, but it can’t reach this lipid in ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives. Data ...

Vancomycin-resistant enterococci (VRE) are multidrug-resistant pathogens and a major cause of nosocomial infections worldwide 1,2. These hospital-acquired pathogens pose a major therapeutic challenge ...

Please provide your email address to receive an email when new articles are posted on . The incidence of SSIs was similar between patients given vancomycin or placebo in addition to standard surgical ...